In an insightful and broad-reaching interview conducted by Wall Street Week, Ted Cronin, Chief Executive and Chief Investment Officer of $1.5 billion wealth manager Manchester Capital, shares his optimism about the U.S. equity markets and observes that experienced judgment, in addition to technical analysis, is needed to identify the best opportunities for investors.
Those prospects have many Venture Capital firms that operate in the U.S., both large and small, visibly nervous, said Rob Fore, a partner in the Silicon Valley office of financial law.
MyInsuranceClub.com, India's second largest insurance comparison website announced today that they have secured a second round of funding from a group of angel investors.
IsraelStartupNetwork and Blumberg Capital announce the winners of their Pitch Fest, held on January 19 in Tel Aviv. Sixteen early-stage Israeli startups competed for an opportunity for due diligence with Blumberg Capital. The three winners - Qmerce, QleeQ and Nooly - were selected by a panel of investors and incubators, and a representative from Microsoft. More than 65 companies applied.
VQ Capital Inc. partners with Advantage Capital Inc. and BFT Ltd. to form a $50 million fund, which will assist new growing and start-up business opportunities in a variety of sectors.
OfferMe, Australia's first Group Buying Platform, is on the verge of finalising a Series A round of substantial venture funding led by overseas investors.
Navasota Group has chosen to establish its EIR Program due to the firm's proven track record of fostering entrepreneurs to build successful, sustainable businesses based on advanced clean technologies.
Independence Equity Management LLC announces the launch of Independence Equity I, a venture capital fund that will invest in early-stage companies commercializing technologies that improve resource utilization. Key sectors of focus include material science, industrial innovation and clean technologies.
Although overall fund-raising was down for the year, in the fourth quarter, firms raised $26.7 billion in 65 funds, up 19% from the $22.5 billion raised by 101 funds in the same period in 2009.
During the fourth quarter of 2010, 126 exits raised $11.8 billion, a slight increase in activity from the same period last year when 123 exits raised $11 billion.
The OSC will undertake a review of our business standards and make recommendations to the Board of Directors and senior management to reinforce the firm's client focus and improve upon the transparency of our activities.
A new topical antibiotic formulation, designed to overcome drug resistance of MRSA, is now available OTC. Known as Tetracycline-ABC, it kills the most drug-resistant and the most deadly bacteria (Staph, MRSA and Acinetobacter), which cause community or hospital acquired infections.